Table 1.
Demographic and clinical characteristics of patients and controls.
| Variables | Control | RA | P value |
|---|---|---|---|
| Number | 97 | 111 | |
| Age (years) | 48.19 ± 12.06 | 46.53 ± 11.89 | 0.321 |
| Gender | 0.054 | ||
| Female n (%) | 76 (78.4%) | 98 (88.3%) | |
| Male n (%) | 21(21.6%) | 13 (11.7%) | |
| BMI kg/m2 | 28.91 ± 4.04 | 29.34 ± 5.83 | 0.544 |
| Smoking Hx positive n (%) | 0.046 | ||
| Current n (%) | 26 (16.5%) | 7 (6.3%) | |
| Former n (%) | 5 (5.2%) | 10 (9%) | |
| Never n (%) | 76 (78.4%) | 94 (84.7%) | |
| Disease duration (years) | 8.67 ± 6.30 | ||
| Active disease n (%) using | 107 (96.4%) | ||
| DAS28 | 111 (100%) | ||
| Active disease n (%) using | 79 (71.2%) | ||
| CDAI | 67 (60.4%) | ||
| RF positive n (%) | 93 (83.8%) | ||
| ACPA positive n (%) | 111 (100%) | ||
| Biologics n (%) | 48 (43.2%) | ||
| DMARDs n (%) | 54 (48.6%) | ||
| NSAIDs n (%) | |||
| Steroids n (%) |
N: number, KG: kilogram, M2:sequare meter, DAS28:Disease Activity score28, CDAI: Clinical Disease Activity Index, RF :Rheumatoid Factor, ACPA: Anti Citrullinated Peptide Antibody, DMARDs: Disease Modifying Anti Rheumatic, NSAIDs: Non-Steroidal Anti Inflammatory Drugs, p value: Probability Value (<0.05) significant, %: percent.